By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

Trump has shut down the USAID work saying that it was not aligned with American strategic interests and wastes money.

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

For decades, lab-made antibodies have been used to support patients fighting specific diseases. These treatments have become ...

UNIGE scientists have developed a groundbreaking technology that creates synthetic molecules mimicking antibodies, potentially revolutionizing disease treatments.

The study explores the potential of chitosan derivatives as novel inhibitors against the wild-type and emerging variants of ...

Chitosan, a naturally occurring polysaccharide derived from chitin, has demonstrated significant potential as an antiviral ...